UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

简称 UROL ONCOL-SEMIN ORI ·UNITED STATES ·出版周期 Bimonthly ·年均收录 219 篇

2.3

最新影响因子

6.30%

自引率

较易

投稿难度

偏慢,4-8周来源Elsevier官…

审稿周期

期刊简介

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS是一本专注于泌尿系统肿瘤研究的国际学术期刊，ISSN号为1078-1439，由Elsevier出版社出版，出版地为荷兰，出版周期为双月刊。该期刊的影响因子根据最新数据在3-4之间，属于SCI收录期刊，中科院分区通常位于医学大类3区或4区，为非开放获取（OA）期刊。其发文特点集中于泌尿肿瘤领域的临床与基础研究，包括前列腺癌、膀胱癌、肾癌等疾病的诊断、治疗和分子机制探索，注重原创性研究和综述文章。杂志质量较高，审稿流程严格，但需注意其影响因子波动可能反映竞争激烈或投稿难度，同时非OA模式可能限制部分读者获取。总体而言，该期刊是泌尿肿瘤领域的重要学术平台，适合高质量研究成果的发表。

影响因子趋势

近期发表

KDM6A suppresses proliferation and epithelial–mesenchymal transition in prostate cancer cells 2026-08-24

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma 2026-08-12

miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression 2026-08-22

Intravesical recurrence is associated with increased Treg and exhausted CD8+ T cells in upper tract urothelial carcinoma 2026-08-17

Reassessing the role of segmental ureterectomy in upper tract urothelial carcinoma: Functional durability and propensity-matched oncological outcomes 2026-08-18

A phase-specific benefit–toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis 2026-08-22

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020 2026-08-12

Defining a hilar “danger zone” to guide surgical decision-making in T1 renal cell carcinoma 2026-08-14

Evaluation, etiology, and management of gross hematuria following radical cystectomy and orthotopic neobladder 2026-08-21

Second primary cancer risk after penile squamous cell carcinoma: A population-based study 2026-08-12